Bristol-Myers Squibb Company
0R1F.IL
Get informed when a big investor buys or sells
+ FollowMarket Cap$121.85B
Close$
Share Statistics
| Market cap | $121.85 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $2.52 (4.22%) |
| Earnings per Share | $- |
| Beta | 0.58 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$1.60
Average shareholder expectationRevenue Estimate
$11.74 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$1.73
Average shareholder expectationRevenue Estimate
$12.69 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bristol-Myers Squibb Company
32,500 employees
CEO: Christopher S. Boerner Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuros...